| Net income | |
| Net loss from discontinued operations | |
| Net income from continuing operations | |
| Depreciation and amortization | |
| Amortization of deferred financing fees | 803K |
| Gain on sale of operating equipment | |
| Share based compensation expense | 1.72M |
| Bad debt expense | |
| Provision for inventory obsolescence | 964K |
| Accounts Receivable | 15.22M |
| Inventories | 7.53M |
| Costs and estimated earnings in excess of billings on uncompleted contracts | |
| Prepaid expenses and other current assets | -2.91M |
| Deferred charges and other assets | |
| Accounts payable and accrued expenses | -10.01M |
| Billings in excess of costs and estimated earnings on uncompleted contracts | 6.86M |
| Accrued income taxes | 2.61M |
| Other liabilities | -1.96M |
| Net cash provided by (used in) continuing operating activities | 52.88M |
| Net cash provided by discontinued operating activities | |
| Net cash provided by operating activities | |
| Acquisition of property and equipment | -811K |
| Net proceeds from sale of property | 301K |
| Net cash provided by (used in) investing activities | |
| Net borrowings on revolving credit lines | |
| Proceeds from exercise of stock options | |
| Cash paid for deferred financing costs | 0 |
| Cash paid for repurchase of common shares | -188K |
| Repayment of term debt | |
| Net cash (used in) provided by financing activities | |
| Net increase in cash | 7.62M |
| Cash and cash equivalents at beginning of the period | 34.19M |
| Cash and cash equivalents at end of the period | 41.81M |
| Conversion of subordinated debt to common stock | |
| Interest | |
| Income taxes | 2.34M |